thiazoles has been researched along with Mycetoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bonifaz, A; Burrows, J; Eadie, K; Fahal, A; Konings, M; Lim, W; Nyuykonge, B; Perry, B; Samby, K; Smeets, J; Todd, M; van de Sande, W; Verbon, A | 1 |
| Abastabar, M; Badali, H; Bonifaz, A; Fahal, A; Lim, W; Nyuykonge, B; van Amelsvoort, L; van de Sande, W; Verbon, A | 1 |
| Campos-Rivera, MP; Escalante-Fuentes, WG; Ocampo-Candiani, J; Pucci, MJ; Vera-Cabrera, L; Welsh, O | 1 |
3 other study(ies) available for thiazoles and Mycetoma
| Article | Year |
|---|---|
Screening the pandemic response box identified benzimidazole carbamates, Olorofim and ravuconazole as promising drug candidates for the treatment of eumycetoma.
Topics: Acetamides; Animals; Antifungal Agents; Ascomycota; Drug Discovery; Drug Evaluation, Preclinical; Fenbendazole; Madurella; Moths; Mycetoma; Neglected Diseases; Piperazines; Pyrimidines; Pyrroles; Thiazoles; Triazoles | 2022 |
Eumycetoma causative agents are inhibited in vitro by luliconazole, lanoconazole and ravuconazole.
Topics: Antifungal Agents; Humans; Imidazoles; Itraconazole; Madurella; Mycetoma; Thiazoles; Triazoles | 2022 |
In vitro activity of ACH-702, a new isothiazoloquinolone, against Nocardia brasiliensis compared with econazole and the carbapenems imipenem and meropenem alone or in combination with clavulanic acid.
Topics: Anti-Bacterial Agents; Clavulanic Acid; Drug Therapy, Combination; Econazole; Humans; Imipenem; In Vitro Techniques; Meropenem; Mycetoma; Nocardia; Nocardia Infections; Quinolones; Thiazoles; Thienamycins | 2010 |